Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFR.L Regulatory News (AFR)

  • There is currently no data for AFR

Form 8 (DD) - Afren Plc

8 Jan 2015 11:05

RNS Number : 6556B
Afren PLC
08 January 2015
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Afren plc ("Afren")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Afren

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

07 January 2015

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of 1p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

nil

nil

(2) Cash-settled derivatives:

 

nil

nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

nil

nil

 

TOTAL:

nil

nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

 

Details of the Afren's directors' interests are set out below:

Directors of Afren

Number of Afren shares

Egbert Imomoh

5,404,411

Darra Comyn

823,605

John St. John

177,823

Iain Mclaren

30,000

Total

6,435,839

 

The directors of the Company have the following beneficial interests in shares in the Company pursuant to the Company 's share option scheme:

 

Egbert Imomoh

No. of Shares

Grant Date

Exercise Price

Exercisable from

Exercisable to

200,000

28/06/2005

20.00p

01/03/2006-01/03/2007

27/06/2015

500,000

28/06/2005

50.00p

28/06/2005-01/03/2006

27/06/2015

500,000

28/06/2005

100.00p

28/06/2005-01/03/2007

27/06/2015

600,000

30/05/2006

63.00p

30/05/2007-30/05/2009

29/05/2016

250,000

28/03/2007

80.00p

28/03/2007-28/03/2010

27/03/2017

250,000

28/03/2007

120.00p

28/03/2007-28/03/2010

27/03/2017

250,000

28/03/2007

180.00p

28/03/2007-28/03/2010

27/03/2017

750,000

23/01/2009

23.25p

23/01/2010-23/01/2012

23/01/2019

Darra Comyn

No. of Shares

Grant Date

Exercise Price

Exercisable from

Exercisable to

650,000

30/12/2009

84.75p

30/12/2010-30/12/2012

30/12/2019

1,200,000

29/03/2010

103.00p

29/03/2011-29/03/2013

28/03/2020

John St. John

No. of Shares

Grant Date

Exercise Price

Exercisable from

Exercisable to

400,000

21/06/2007

70.00p

21/06/2007-21/06/2009

20/06/2017

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

08 January 2015

Contact name:

Anne Vallely

Telephone number:

+44 20 7864 3700

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCPKFDKDBKDNDK
Date   Source Headline
29th Oct 20137:12 amRNSConference presentation
1st Oct 201310:14 amRNSShareholding in the Company & Total Voting Rights
19th Sep 20139:05 amRNSNotifications of Transactions of PDMR
12th Sep 20134:50 pmRNSNotifications of Transactions of PDMR
12th Sep 20134:50 pmRNSNotifications of Transactions of PDMR
12th Sep 20134:50 pmRNSNotifications of Transactions of PDMR
12th Sep 20134:50 pmRNSNotifications of Transactions of PDMR
12th Sep 20134:50 pmRNSNotifications of Transactions of PDMR
12th Sep 20134:50 pmRNSNotifications of Transactions of PDMR
12th Sep 20133:52 pmRNSNotification of Transactions by PDMR
9th Sep 201312:45 pmRNSNotifications of Transactions of PDMR
9th Sep 201312:45 pmRNSNotifications of Transactions of PDMR
9th Sep 201312:45 pmRNSNotifications of Transactions of PDMR
9th Sep 201312:45 pmRNSNotifications of Transactions of PDMR
9th Sep 201312:45 pmRNSNotifications of Transactions of PDMR
9th Sep 201312:45 pmRNSNotifications of Transactions of PDMR
3rd Sep 20131:10 pmRNSShareholding in the Company
23rd Aug 20137:00 amRNS2013 Half-yearly Results
1st Aug 20132:50 pmRNSTotal Voting Rights
5th Jul 20137:00 amRNSDirectors to acquire Afren shares
5th Jul 20137:00 amRNSAcquisition of an additional interest in FHN
1st Jul 201310:29 amRNSShareholding in the Company & Total Voting Rights
26th Jun 20137:00 amRNSSignificant oil discovery offshore Nigeria
24th Jun 20139:49 amRNSBlock Listing Six Monthly Return
11th Jun 20133:00 pmRNSResult of Annual General Meeting
11th Jun 201311:00 amRNSAnnual General Meeting - Chairman's statement
7th Jun 20131:38 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Jun 20139:54 amRNSTotal Voting Rights
29th May 20132:59 pmRNSCompletion of acquisition
20th May 20133:25 pmRNSResult of General Meeting
20th May 20132:31 pmRNSGeneral Meeting - Chairman's statement
16th May 20137:00 amRNSInterim Management Statement
14th May 20137:00 amRNSOPL 310 - farm out agreement
13th May 20135:53 pmRNSNotification by Company
3rd May 20137:00 amRNSNotice of General Meeting
2nd May 20135:25 pmRNSTotal Voting Rights
30th Apr 20137:00 amRNSAnnual Report & Notice of General Meeting
2nd Apr 20131:24 pmRNSNotification by Company
2nd Apr 201310:50 amRNSShareholding in the Company & Total Voting Rights
25th Mar 20137:01 amRNSRecommended acquisition of 10.4% of FHN
25th Mar 20137:00 amRNS2012 Full Year Results
20th Mar 20137:00 amRNSTR-1:Notification of Major Interest in Shares
13th Mar 20137:00 amRNSPositive test results from the Simrit-2 well
4th Mar 20139:39 amRNSShareholding in the Company & Total Voting Rights
1st Feb 201310:51 amRNSShareholding in the Company & Total Voting Rights
1st Feb 201310:29 amRNSNotifications of Major Interests in Shares
30th Jan 20135:02 pmRNSNotification of Major Interest in Shares
21st Jan 20137:00 amRNSTrading statement and operations update
21st Jan 20137:00 amRNSNotification of Major Interest in Shares
14th Jan 201312:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.